Framingham Union has until May 9 to prepare a plan explaining how the hospital’s special care nursery services will be ...

Sanofi signed a deal with Earendil Labs for $125 million upfront and $1.72 billion in milestone payments. Regeneron ...

Marylou's Coffee began in 1986 by opening in Hanover. The chain has now blossomed into more than 40 locations, mostly on ...

The company reiterated its financial outlook for the year but is struggling to predict the likely impact of pharmaceutical ...

Disclaimer: The views and investment tips by experts in this News18.com report are their own and not those of the website or its management. Users are advised to check with certified experts before ...

Sanofi and Regeneron Pharmaceuticals drug Dupixent has won FDA approval for chronic spontaneous urticaria, introducing a new approach to the treatment of this inflammatory skin disorder. It’s ...

The US State Department is warning Americans against traveling to part of one Central America country and has issued a do not travel warning for one of its neighboring nations. Arauca, Cauca ...

Paris: Sanofi and Regeneron Pharma have received approval from the US Food and Drug Administration (FDA) for Dupixent (dupilumab) for the treatment of adults and adolescents aged 12 years and older ...

But the up-front costs are large, so pilot projects like one in Framingham, Massachusetts, are using the deep pockets of gas utilities to build geothermal networks that collect affordable payments ...

- 10,000 Pref. and 10,000 No. of Equity shares of Rs 100 each issued to promoters. 5000 Pref. and 9,867 No. of Equity shares as Rights in proportion to holdings.

Regeneron Pharmaceuticals and Sanofi won U.S. Food and Drug Administration expanded approval of their blockbuster anti-inflammatory drug Dupixent for the inflammatory skin condition chronic ...